ADMA Biologics ADMA Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from ADMA Biologics’s reported figures.
Based on the most recent quarter.
The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is ADMA Biologics's current ratio?
- ADMA Biologics (ADMA) reported current ratio of 7× in Q1 2026.
- How has ADMA Biologics's current ratio changed year-over-year?
- ADMA Biologics's current ratio increased by 5.7% year-over-year, from 6.6× to 7×.
- What is the long-term trend for ADMA Biologics's current ratio?
- Over 5 years (2020 to 2025), ADMA Biologics's current ratio has grown at a -2.7% compound annual growth rate (CAGR), from 7.7× to 6.7×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.